Other languages Societal CDMO, Inc.

Equities

SCTL

US75629F1093

Market Closed - Nyse Other stock markets 04:00:00 2024-04-05 pm EDT			5-day change	1st Jan Change
1.1 ^USD	+0.92%		0.00%	+213.84%

Apr. 08	Societal CDMO, Inc. Announces Board and Committee Resignations	CI
Apr. 08	Societal CDMO, Inc.(NasdaqCM:SCTL) dropped from NASDAQ Composite Index	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Societal CDMO, Inc. Announces Board and Committee Resignations	Apr. 08
CoreRx, Inc. completed the acquisition of Societal CDMO, Inc. from First Light Asset Management, LLC and Others.	Apr. 07
Societal CDMO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22
Wall Street Set to Open Higher Thursday as Inflation Data Meets Forecasts	Feb. 29
Investors Await Slate of Economic Data as US Futures Move Lower in Thursday's Premarket Session	Feb. 29
Societal CDMO Signs Co-Marketing Deal With Benuvia Operations	Feb. 01
Societal CDMO, Inc and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers	Feb. 01
Societal CDMO, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08
Societal CDMO, Inc. Resets Earnings Guidance for the Year 2023	Nov. 08
Societal CDMO, Inc. Reduces its Workforce by 26 Positions Across All Aspects of the Business	23-09-21
Societal CDMO, Inc. Appoints Wayne Weisman as Executive Chairman	23-09-21
Societal Cdmo Secures Project Expansion Agreements with Several Existing Customers	23-09-07
Sector Update: Health Care Stocks Slipping Late Afternoon	23-08-24
Sector Update: Health Care	23-08-24
Top Midday Decliners	23-08-24
Societal CDMO Starts Stock Offering; Shares Slump After-Hours	23-08-23
Societal Cdmo Announces Appointment of Matt Arens to Board of Directors	23-08-23
Societal CDMO, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Societal CDMO to Support Spinnaker Biosciences' Clinical Development of New Therapeutic Candidate	23-07-10
Spinnaker Biosciences Selects Societal CDMO to Provide CDMO Services to Support Clinical Development of Novel Therapeutic Candidate	23-07-10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Societal CDMO, Inc.

Equities

SCTL

US75629F1093

Other languages

Filters